Clinical Trials

Esophageal Squamous Cell Carcinoma

NCT07519486 2026-04-15

INS-ESCC-CT

Phase 2 Recruiting

118 enrolled

Phase 2 Not yet recruiting

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT07505186 2026-04-01

Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma

45 enrolled

Phase 2 Active not recruiting

Esophageal Squamous Cell Carcinoma

NCT05659251 2025-12-02

Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma

48 enrolled

Esophageal Squamous Cell Carcinoma

NCT06576973 2025-12-02

Adbelimumab Combined With Chemotherapy and Apatinib in Patients With Resectable Esophageal Squamous Cell Carcinoma

Phase 2 Recruiting

35 enrolled

Phase 2 Active not recruiting

Esophageal Squamous Cell Carcinoma

NCT04666090 2025-05-15

Carrelizumab, Chemotherapy and Apatinib in the Neoadjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma

42 enrolled

Esophageal Squamous Cell Carcinoma

NCT00318903 2023-05-25

Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer

25 enrolled

Esophageal Neoplasms

NCT02965976 2023-02-16

Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer

33 enrolled 17 charts

Esophageal Neoplasms

NCT05596890 2022-11-28

PICCRT

50 enrolled

Esophageal Squamous Cell Carcinoma, Deglutition Disorders

NCT05245760 2022-11-08

CRATER

Phase 2 Withdrawn

Esophageal Neoplasms

NCT03529266 2021-08-24

PLACE020

57 enrolled

Esophageal Neoplasms, Anastomotic Leak

NCT04006041 2019-12-26

Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer

44 enrolled

Esophageal Squamous Cell Carcinoma, Pathologic Complete Response

NCT02858206 2019-07-26

Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma

120 enrolled

Esophageal Neoplasms

NCT01372202 2019-01-25

J10130

Phase 2 Terminated

31 enrolled 11 charts

Esophageal Neoplasms

NCT03223662 2018-10-30

Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision Therapy

Phase 2 Terminated

2 enrolled 6 charts

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT00137852 2017-09-20

Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer

35 enrolled

Esophageal Neoplasms

NCT00570531 2016-05-26

Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma

Phase 2 Terminated

6 enrolled 5 charts

Loco-regional Esophageal Cancer

NCT01349517 2011-11-11

Health-related Quality of Life of Patients With Esophageal Cancer After Surgery

400 enrolled

Esophageal Neoplasms

NCT01034332 2009-12-18

Paclitaxel/Cisplatin/Fluorouracil Followed by Paclitaxel/Cisplatin/Radiotherapy and Esophagectomy for Esophageal Cancer

58 enrolled